Literature DB >> 21140426

Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.

Shogo Kobayashi1, Hiroaki Nagano, Hiromitsu Hoshino, Hiroshi Wada, Shigeru Marubashi, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Tonsok Kim, Eku Shimosegawa, Jun Hatazawa, Yuichiro Doki, Masaki Mori.   

Abstract

BACKGROUND AND OBJECTIVES: Histopathologically confirmed lymph node metastasis is a prognostic factor in the surgical treatment of biliary tract cancer, however, preoperative diagnosis is still difficult even with computed tomography. FDG-PET has been used for the diagnosis of cancer and metastatic lesions. Herein, we retrospectively evaluated the utility of FDG-PET for detection of lymph node metastasis in biliary tract cancer.
METHODS: We measured SUV(max) at each 190 surgically dissected lymph node area in 36 patients, and compared the values with histopathological diagnosis. The cutoff values for SUV(max) were defined from the ROC curve and the mean plus two standard deviations then used for detection of metastatic lymph node and prognostic value, compared with CT diagnosis.
RESULTS: The sensitivity, specificity, and positive predictive value of FDG-PET were better than CT diagnosis (86%, 74%, 43% for SUV(max) ≥ 2.0, and 37%, 97%, 72% for SUV(max) ≥ 2.8, respectively). There was no relationship between SUV(max) and CT-determined lymph node dimensions. The presence of SUV(max) ≥ 2.8 lymph nodes was an independent determinant of prognosis after surgical treatment.
CONCLUSION: The detection of metastatic lymph nodes by FDG-PET is limited, but better than CT. SUV(max) for lymph nodes seems useful for clinical decision-making regarding treatment strategy including surgery.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140426     DOI: 10.1002/jso.21811

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors.

Authors:  Shigeru Marubashi; Kunihito Gotoh; Hidenori Takahashi; Hiroaki Ohigashi; Masahiko Yano; Osamu Ishikawa; Masato Sakon
Journal:  Dig Dis Sci       Date:  2014-01       Impact factor: 3.199

2.  Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma.

Authors:  Takehiro Noji; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Satoshi Hirano
Journal:  J Gastrointest Surg       Date:  2021-01-05       Impact factor: 3.452

3.  Retrocrural Lymph Node Metastasis Disclosed by (18)F-FDG PET/CT: A Predictor of Supra-diaphragmatic Spread in Ovarian Cancer.

Authors:  Hyung-Jun Im; Yong-Il Kim; Jin Chul Paeng; June-Key Chung; Soon-Beom Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2011-10-28

4.  Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery.

Authors:  Prithivi Raj; Lileswar Kaman; Rajinder Singh; Divya Dahyia; Anish Bhattacharya; Amanjit Bal
Journal:  Updates Surg       Date:  2013-03-16

5.  Laparoscopic total biopsy for suspected gallbladder cancer: A case series.

Authors:  Yukio Tokumitsu; Yoshitaro Shindo; Hiroto Matsui; Satoshi Matsukuma; Masao Nakajima; Shin Yoshida; Michihisa Iida; Nobuaki Suzuki; Shigeru Takeda; Hiroaki Nagano
Journal:  Health Sci Rep       Date:  2020-04-20

6.  Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer.

Authors:  Kotaro Shimura; Seiji Mabuchi; Naoko Komura; Eriko Yokoi; Katsumi Kozasa; Tomoyuki Sasano; Mahiru Kawano; Yuri Matsumoto; Tadashi Watabe; Michiko Kodama; Kae Hashimoto; Kenjiro Sawada; Jun Hatazawa; Tadashi Kimura
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

7.  Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma.

Authors:  Yan-Jie Shi; Bo-Nan Liu; Xiao-Ting Li; Hai-Tao Zhu; Yi-Yuan Wei; Bo Zhao; Shao-Shuai Sun; Ying-Shi Sun; Chun-Yi Hao
Journal:  Abdom Radiol (NY)       Date:  2021-11-20

8.  Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers.

Authors:  Kathryn J Schunke; Lauren M Rosati; Marianna Zahurak; Joseph M Herman; Amol K Narang; Irina Usach; Alison P Klein; Charles J Yeo; Larry T Korman; Ralph H Hruban; John L Cameron; Daniel A Laheru; Ross A Abrams
Journal:  Adv Radiat Oncol       Date:  2017-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.